"Ethinyl Estradiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
| Descriptor ID |
D004997
|
| MeSH Number(s) |
D04.210.500.668.651.568.291 D06.472.334.851.437.968.500
|
| Concept/Terms |
Ethinyl Estradiol- Ethinyl Estradiol
- Estradiol, Ethinyl
- Ethinyloestradiol
- Ethynyl Estradiol
- Estradiol, Ethynyl
|
Below are MeSH descriptors whose meaning is more general than "Ethinyl Estradiol".
Below are MeSH descriptors whose meaning is more specific than "Ethinyl Estradiol".
This graph shows the total number of publications written about "Ethinyl Estradiol" by people in this website by year, and whether "Ethinyl Estradiol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ethinyl Estradiol" by people in Profiles.
-
Haas DW, Cramer YS, Godfrey C, Rosenkranz SL, Aweeka F, Berzins B, Coombs R, Coughlin K, Moran LE, Gingrich D, Zorrilla CD, Baker P, Cohn SE, Scarsi KK. Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives. Pharmacogenet Genomics. 2020 04; 30(3):45-53.
-
Wang G, Ma P, Zhang Q, Lewis J, Lacey M, Furukawa Y, O'Reilly SE, Meaux S, McLachlan J, Zhang S. Endocrine disrupting chemicals in New Orleans surface waters and Mississippi Sound sediments. J Environ Monit. 2012 May; 14(5):1353-64.
-
Kaneshiro B, Edelman A, Carlson NE, Nichols M, Forbes MM, Jensen J. A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use. Contraception. 2012 Apr; 85(4):351-8.
-
Mathews E, Braden TD, Williams CS, Williams JW, Bolden-Tiller O, Goyal HO. Mal-development of the penis and loss of fertility in male rats treated neonatally with female contraceptive 17alpha-ethinyl estradiol: a dose-response study and a comparative study with a known estrogenic teratogen diethylstilbestrol. Toxicol Sci. 2009 Dec; 112(2):331-43.
-
Fontenot HB, Harris AL. The latest advances in hormonal contraception. J Obstet Gynecol Neonatal Nurs. 2008 May-Jun; 37(3):369-74.
-
Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S. Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res. 2004; 6(1):R31-7.
-
Rice VM. Optimizing the dose of hormone replacement therapy. Int J Fertil Womens Med. 2002 Sep-Oct; 47(5):205-10.
-
Montgomery Rice V. Hormone replacement therapy: optimising the dose and route of administration. Drugs Aging. 2002; 19(11):807-18.
-
Dunston GM, Gershowitz H. A hormonally influenced human serum globulin: elevation of Xh by estrogen. J Lab Clin Med. 1974 Aug; 84(2):187-90.